| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 160.694 | 205.419 | 240.865 | 234.562 | 221.612 | 252.904 | 257.595 | 393.964 | 327.405 | 303.906 |
| Total Income - EUR | 160.698 | 205.420 | 240.865 | 234.562 | 221.612 | 261.670 | 267.874 | 394.603 | 327.405 | 303.906 |
| Total Expenses - EUR | 143.550 | 186.775 | 219.292 | 205.266 | 200.201 | 193.348 | 254.223 | 337.508 | 336.857 | 306.237 |
| Gross Profit/Loss - EUR | 17.148 | 18.645 | 21.572 | 29.297 | 21.411 | 68.322 | 13.651 | 57.095 | -9.453 | -2.331 |
| Net Profit/Loss - EUR | 14.330 | 15.541 | 16.863 | 26.951 | 19.301 | 66.276 | 11.075 | 53.155 | -12.727 | -5.371 |
| Employees | 11 | 0 | 12 | 10 | 11 | 11 | 11 | 8 | 15 | 15 |
Check the financial reports for the company - Polivizmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.986 | 13.607 | 46.598 | 42.174 | 34.283 | 26.476 | 29.610 | 33.752 | 44.105 | 32.181 |
| Current Assets | 43.402 | 59.332 | 37.511 | 40.861 | 48.066 | 62.587 | 68.733 | 91.407 | 94.830 | 59.032 |
| Inventories | 181 | 2.277 | 3.344 | 1.134 | 1.339 | 932 | 985 | 1.962 | 1.043 | 788 |
| Receivables | 40.670 | 46.813 | 32.355 | 35.569 | 41.735 | 48.971 | 61.996 | 74.129 | 84.246 | 48.244 |
| Cash | 2.551 | 10.242 | 1.812 | 4.158 | 4.992 | 12.684 | 5.752 | 15.316 | 9.541 | 10.000 |
| Shareholders Funds | 22.917 | 15.585 | 16.916 | 43.556 | 45.780 | 66.326 | 11.124 | 64.313 | 51.391 | -17.978 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 35.471 | 57.354 | 67.194 | 39.479 | 36.569 | 22.738 | 87.220 | 60.846 | 87.544 | 109.191 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Polivizmed Srl